Insufficient scRNA-seq data for expression of NHLH1 at single-cell level.
Insufficient scRNA-seq data for expression of NHLH1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 98% | 122.98 | 2602 / 2642 | 47% | 3.21 | 329 / 705 |
adrenal gland | 78% | 18.10 | 201 / 258 | 47% | 1.32 | 109 / 230 |
spleen | 99% | 82.99 | 239 / 241 | 0% | 0 | 0 / 0 |
skin | 93% | 32.04 | 1675 / 1809 | 6% | 0.09 | 28 / 472 |
lung | 87% | 31.11 | 500 / 578 | 5% | 0.08 | 60 / 1155 |
esophagus | 73% | 16.64 | 1055 / 1445 | 14% | 0.40 | 26 / 183 |
breast | 78% | 20.17 | 358 / 459 | 7% | 0.11 | 80 / 1118 |
peripheral blood | 84% | 70.27 | 781 / 929 | 0% | 0 | 0 / 0 |
muscle | 81% | 24.89 | 652 / 803 | 0% | 0 | 0 / 0 |
adipose | 81% | 24.68 | 972 / 1204 | 0% | 0 | 0 / 0 |
prostate | 78% | 18.62 | 191 / 245 | 1% | 0.01 | 5 / 502 |
intestine | 74% | 18.60 | 719 / 966 | 1% | 0.03 | 7 / 527 |
kidney | 73% | 16.53 | 65 / 89 | 2% | 0.03 | 18 / 901 |
stomach | 65% | 14.43 | 235 / 359 | 2% | 0.03 | 6 / 286 |
ovary | 50% | 10.38 | 90 / 180 | 16% | 0.27 | 70 / 430 |
uterus | 55% | 9.40 | 93 / 170 | 9% | 0.19 | 42 / 459 |
liver | 61% | 15.39 | 138 / 226 | 0% | 0.00 | 1 / 406 |
thymus | 60% | 12.59 | 395 / 653 | 0% | 0.00 | 2 / 605 |
bladder | 52% | 10.43 | 11 / 21 | 5% | 1.41 | 25 / 504 |
blood vessel | 56% | 11.17 | 753 / 1335 | 0% | 0 | 0 / 0 |
pancreas | 30% | 5.02 | 100 / 328 | 3% | 0.04 | 5 / 178 |
heart | 33% | 5.95 | 281 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 10% | 0.13 | 3 / 29 |
tonsil | 0% | 0 | 0 / 0 | 2% | 0.02 | 1 / 45 |
eye | 0% | 0 | 0 / 0 | 1% | 0.02 | 1 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007417 | Biological process | central nervous system development |
GO_0030154 | Biological process | cell differentiation |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0046983 | Molecular function | protein dimerization activity |
GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO_0000977 | Molecular function | RNA polymerase II transcription regulatory region sequence-specific DNA binding |
GO_0005515 | Molecular function | protein binding |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
Gene name | NHLH1 |
Protein name | Nescient helix loop helix 1 Helix-loop-helix protein 1 (HEN-1) (Class A basic helix-loop-helix protein 35) (bHLHa35) (Nescient helix loop helix 1) (NSCL-1) |
Synonyms | BHLHA35 HEN1 hCG_20859 |
Description | FUNCTION: May serve as DNA-binding protein and may be involved in the control of cell-type determination, possibly within the developing nervous system. |
Accessions | ENST00000302101.6 Q5T203 Q02575 |